Latest Breaking News On - Gastroenterology center - Page 1 : vimarsana.com

Paul Feuerstadt, MD: Safety, Efficacy of Live-jslm in Patients Taking Concomitant Medications

Feuerstadt breaks down findings from an ad hoc analysis of PUNCH CD3 and what the results suggest about the use of live-jslm (Rebyota) in patients taking concomitant medications.

Q&A: DIY fecal microbiota transplantation a risky game of 'Russian roulette'

GI cancer screening topped headlines in 2023: Did your patients get the message?

'The future is here': New products join armamentarium for C. difficile

30 new GI centers in 2023

Explore the 30 gastroenterology and endoscopy centers that were opened or announced in 2023!

Current Trends, Treatment Strategies for C diff Infection

Paul Feuerstadt, MD, FACG, AGAF, discusses insights in current treatment practices for CDI at the Peggy Lillis Foundation’s 2023 State of C diff Virtual Town Hall.

Newsworthy people and performances for Oct. 30, 2023

Better Fecal Live Microbiota Outcomes Linked to Gut Microbiome Health

New PUNCH CD3 analyses show patients who were treated with live fecal microbiota therapy improved their gut health at 8 weeks—which correlated with improved quality-of-life scores.

Paul Feuerstadt, MD: Preventing Recurrent C Difficile in Older Adults with Comorbidities

Feuerstadt reviews ACG 2023 data showing live microbiota therapy provides consistent protection against rCDI in one of the most vulnerable patient populations.

Fecal transplant 'not over yet' for C. difficile despite boom in live microbiota therapies